Glucagon (Xeris Pharmaceuticals)

N/A

Report date: 2025/12/05 16:14:38

Base Information

Drug NameGlucagon (Xeris Pharmaceuticals)
Drug Alias NameG-PenInjectable stable glucagon - XerisGlucagon infusion - XerisXeris glucagonXeriSol G-Pump +[11
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon receptor agonists
TargetsGlucagon receptor
Therapy Area/IndicationsHypoglycemiaHyperinsulinism
Global Approved IndicationsHypoglycemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2019/09/10
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesXeris Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypoglycemia
Inactive IndicationsHyperinsulinism

Other Information

ATC CodeH04AA01
Related LinksDrugBankKEGG